Роль адъювантной химиотерапии у больных раком прямой кишки после предоперационной химиолучевой терапии: результаты ретроспективного исследования

1. Федянин М.Ю., Трякин А.А., Тюляндин С.А. Адъювантная химиотерапия после химиолучевого лечения местнораспространенного рака прямой кишки. Онкологическая колопроктология 2014;(2):5–12.

2. Rectal cancer. NCCN Clinical Practical Guidelines in Oncology. Version 3.2017. Available at: http://www.nccn.org/professionals/physician_gls/pdf/rectal.pdf.

3. Glynne-Jones R., Wyrwicz L., Tiret E. et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2017;28(Suppl 4):iv22–40. PMID: 28881920. DOI: 10.1093/annonc/mdx224.

4. Poulsen L.O., Qvortrup C., Pfeiffer P. et al. Review on adjuvant chemotherapy for rectal cancer why do treatment guidelines differ so much? Acta Oncol 2015;54(4):437–46. PMID: 25597332. DOI: 10.3109/0284186X.2014.993768.

5. Гордеев С.С. Варианты неоадъювантной химиолучевой терапии больных местно-распространенным раком прямой кишки. Автореф. дис. … канд. мед. наук. М., 2013..

6. Алиев В.А. Выбор тактики лечения больных колоректальным раком с синхронными отдаленными метастазами. Автореф. дис. … д-ра мед. наук. М., 2015.

7. Govindarajan A., Reidy D., Weiser M.R. et al. Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision. Ann Surg Oncol 2011;18(13):3666–72. PMID: 21590450. DOI: 10.1245/s10434-011-1788-y.

8. Das P., Skibber J.M., Rodriguez-Bigas M.A. et al. Clinical and pathologic predictors of locoregional recurrence, distant metastasis and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer. Am J Clin Oncol 2006;29(3):219–24. PMID: 16755173. DOI: 10.1097/01. coc.0000214930.78200.4a.

9. Janjan N.A., Crane C., Feig B.W. et al. Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. Am J Clin Oncol 2001;24(2):107–12. PMID: 11319280

10. Glynne-Jones R., Councell N., Meadows M. et al. CHRONICLE: a phase III trail in locally advanced rectal cancer after neoadjuvant chemoradiation randomizing postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus control. Ann Oncol 2014;25(7):1356–62. PMID: 24718885. DOI: 10.1093/annonc/mdu147.

11. Reinel H., Schäßburger K., Meyer D. et al. 5-fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) as postoperative adjuvant chemotherapy (CT) for node-positive rectal cancer after radiochemotherapy (R-CT) and surgery. J Clin Oncol 2010;28(Suppl 15):e14125. DOI: 10.1200/jco.2010.28.15_suppl.e14125.

12. Hofheinz R.D., Wenz F., Post S. et al. Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial. Lancet Oncol 2012;13(6):579–88. PMID: 22503032. DOI: 10.1016/S1470-2045(12)70116-X.

13. Ngan S.Y., Burmeister B., Fisher R.J. et al. Randomised trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group Trial 01.04. J Clin Oncol 2012;30:3827–33. PMID: 23008301. DOI: 10.1200/JCO.2012.42.9597.

14. Maas M., Nelemans P.J., Valentini V. et al. Adjuvant chemotherapy in rectal cancer: defining subgroups who may benefit after neoadjuvant chemoradiation and resection: a pooled analysis of 3 313 patients. Int J Cancer 2015;137(1):212–20. PMID: 25418551. DOI: 10.1002/ijc.29355.

15. Polanco P.M., Mokdad A.A., Zhu H. et al. Association of adjuvant chemotherapy with overall survival in patients with rectal cancer and pathologic complete response following neoadjuvant chemotherapy and resection. JAMA Oncol 2018. PMID: 29710272. DOI: 10.1001/jamaoncol.2018.0231.

16. Hong Y.S., Nam B.H., Jung K.H. et al. Adjuvant chemotherapy with oxaliplatin/5fluorouracil/leucovorin (FOLFOX) versus 5-fluorouracil/leucovorin (FL) in patients with locally advanced rectal cancer after preoperative chemoradiotherapy followed by surgery: a randomized phase II study (The ADORE). J Clin Oncol 2013;31(Suppl):abstr.3570.

17. Rӧdel C., Liersch T., Becker H. et al. Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initia results of the German CAO/ARO/AIO-04 randomised phase 3 trial. Lancet Oncol 2012;13(7):679–87. PMID: 22627104. DOI: 10.1016/S14702045(12)70187-0

18. Gresham G., Speers C., Woods R. et al. Association of time to adjuvant chemotherapy (TTAC) and overall survival among patients with rectal cancer treated with preoperative radiation. J Clin Oncol 2013;31(4 Suppl):461. DOI: 10.1200/jco.2013.31.4_suppl.461.

Рецензия

Контент доступен под лицензией Creative Commons Attribution 4.0 License.

ISSN 2949-5857 (Online)

Логин
Пароль
	Запомнить меня

Войти

Хирургия и онкология

Роль адъювантной химиотерапии у больных раком прямой кишки после предоперационной химиолучевой терапии: результаты ретроспективного исследования

Полный текст:

Аннотация

Ключевые слова

Об авторах

Список литературы

Рецензия

Использование куки-файлов